Morgan Stanley’s Strata Skin Sciences SSKN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1
Closed -$2 8444
2025
Q3
$2 Hold
1
﹤0.01% 8147
2025
Q2
$2 Hold
1
﹤0.01% 8076
2025
Q1
$3 Hold
1
﹤0.01% 8059
2024
Q4
$3 Hold
1
﹤0.01% 7948
2024
Q3
$3 Hold
1
﹤0.01% 7905
2024
Q2
$3 Sell
1
-50
-98% -$203 ﹤0.01% 7827
2024
Q1
$193 Sell
51
-51
-50% -$266 ﹤0.01% 7313
2023
Q4
$562 Buy
102
+51
+100% +$265 ﹤0.01% 7270
2023
Q3
$303 Hold
51
﹤0.01% 7356
2023
Q2
$484 Hold
51
﹤0.01% 7378
2023
Q1
$540 Hold
51
﹤0.01% 7420
2022
Q4
$403 Sell
51
-36
-41% -$309 ﹤0.01% 7581
2022
Q3
$1K Buy
87
+36
+71% +$366 ﹤0.01% 7603
2022
Q2
$0 Buy
51
+9
+21% +$107 ﹤0.01% 7961
2022
Q1
$1K Buy
+42
New +$627 ﹤0.01% 7867
2021
Q1
Sell
-4
Closed 7557
2020
Q4
$0 Buy
+4
New +$58 ﹤0.01% 7107
2020
Q2
Sell
-2
Closed 6715
2020
Q1
$0 Sell
2
-37
-95% -$611 ﹤0.01% 6697
2019
Q4
$1K Buy
+39
New +$885 ﹤0.01% 6589
2018
Q4
Sell
-12,237
Closed -$434K 6728
2018
Q3
$434K Buy
12,237
+9,673
+377% +$238K ﹤0.01% 5075
2018
Q2
$53K Buy
+2,564
New +$41.9K ﹤0.01% 5903
2017
Q3
Sell
-801
Closed -$19K 6607
2017
Q2
$19K Buy
801
+799
+39,950% +$22.3K ﹤0.01% 6102
2017
Q1
$0 Sell
2
-25
-93% -$710 ﹤0.01% 6608
2016
Q4
$1K Buy
27
+2
+8% +$51 ﹤0.01% 6458
2016
Q3
$1K Sell
25
-19
-43% -$605 ﹤0.01% 6442
2016
Q2
$1K Hold
44
﹤0.01% 6443
2016
Q1
$2K Hold
44
﹤0.01% 6410
2015
Q4
$2K Sell
44
-1
-2% -$57 ﹤0.01% 6514
2015
Q3
$3K Hold
45
﹤0.01% 6454
2015
Q2
$3K Sell
45
-1
-2% -$81 ﹤0.01% 6479
2015
Q1
$6K Buy
46
+3
+7% +$296 ﹤0.01% 6312
2014
Q4
$3K Buy
43
+20
+87% +$1.64K ﹤0.01% 6401
2014
Q3
$2K Sell
23
-1
-4% -$117 ﹤0.01% 6446
2014
Q2
$4K Sell
24
-5
-17% -$1.13K ﹤0.01% 6319
2014
Q1
$9K Sell
29
-14
-33% -$4.92K ﹤0.01% 6147
2013
Q4
$13K Buy
+43
New +$15.4K ﹤0.01% 5983
2013
Q3
Sell
-23
Closed -$11K 5383
2013
Q2
$11K Buy
+23
New +$12.3K ﹤0.01% 5303

Other funds holding SSKN

Morgan Stanley's SSKN Position: Q4 2025 in Review

Morgan Stanley sold out of Strata Skin Sciences (SSKN) in Q4 2025, closing a stake of 1 share — an estimated $2 sold.

Morgan Stanley first reported a position in SSKN in Q2 2013 and held it in 36 quarters. The position peaked at $434K in Q3 2018. 14 funds tracked by Wall St. Rank hold SSKN as of Q4 2025.

  • Morgan Stanley reported no remaining Strata Skin Sciences position as of Q4 2025 after selling out during the quarter.
  • Morgan Stanley sold 1 Strata Skin Sciences share in Q4 2025, an estimated $2.
  • Morgan Stanley first reported a position in Strata Skin Sciences in Q2 2013 and held it in 36 quarters.
  • Morgan Stanley's Strata Skin Sciences position peaked at $434K in Q3 2018.
  • 14 funds tracked by Wall St. Rank held Strata Skin Sciences as of Q4 2025.

Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.